519P Final results and subgroup analysis of ORIENTAL: A phase IIIB study of durvalumab plus platinum-etoposide in first-line treatment of Chinese patients with extensive-stage small-cell lung cancer (ES-SCLC).

Authors :: Cheng, Y.
Wang, J.
Yao, W.
Yu, Y.
Zang, A.
Cao, L.
Lv, D.
Li, S.
Meng, Z.
Zhang, J.
Guo, Q.
Huang, D.
Liu, A.
Liu, J.
Mao, W.
Tang, K.
Zhang, Y.
Chen, E.
Wang, Z.
Zheng, J.
Source :: Annals of Oncology. 2023 Supplement 4, Vol. 34, pS1673-S1673. 1p.
Publication Year :: 2023

Subjects :: *CHINESE people
*LUNG cancer
*SUBGROUP analysis (Experimental design)
*THERAPEUTICS

Full Text Access

Tools